These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 32270178)

  • 1. Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus.
    Zhao J; Liao X; Wang H; Wei L; Xing M; Liu L; Zhang Z
    Clin Infect Dis; 2020 Nov; 71(16):2233-2235. PubMed ID: 32270178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia.
    Masyeni S; Santoso MS; Widyaningsih PD; Asmara DW; Nainu F; Harapan H; Sasmono RT
    Int J Infect Dis; 2021 Jan; 102():152-154. PubMed ID: 33115680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus.
    Bailey JR; Dowd KA; Snider AE; Osburn WO; Mehta SH; Kirk GD; Thomas DL; Ray SC
    J Infect Dis; 2015 Sep; 212(6):914-23. PubMed ID: 25754978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and Mycoplasma pneumoniae: SARS-CoV-2 false positive or coinfection?
    Monte Serrano J; García-Gil MF; Cruañes Monferrer J; Aldea Manrique B; Prieto-Torres L; García García M; Matovelle Ochoa C; Ara-Martín M
    Int J Dermatol; 2020 Oct; 59(10):1282-1283. PubMed ID: 32767368
    [No Abstract]   [Full Text] [Related]  

  • 8. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4
    Wang M; Luo L; Bu H; Xia H
    Int J Infect Dis; 2020 Jul; 96():148-150. PubMed ID: 32335339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Bahar B; Jacquot C; Mo YD; DeBiasi RL; Campos J; Delaney M
    J Pediatr; 2020 Dec; 227():31-37.e1. PubMed ID: 32891640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients.
    Zilla ML; Keetch C; Mitchell G; McBreen J; Shurin MR; Wheeler SE
    J Appl Lab Med; 2021 Mar; 6(2):486-490. PubMed ID: 33367709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinfection between SARS-CoV-2 and HIV with a low CD4+ T-cells count.
    Suryana K CS
    Med J Malaysia; 2021 May; 76(3):446-448. PubMed ID: 34031352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
    Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
    Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between hepatitis B virus and SARS-CoV-2 infections.
    Xiang TD; Zheng X
    World J Gastroenterol; 2021 Mar; 27(9):782-793. PubMed ID: 33727770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study.
    Liu R; Zhao L; Cheng X; Han H; Li C; Li D; Liu A; Gao G; Zhou F; Liu F; Jiang Y; Zhu C; Xia Y
    Liver Int; 2021 Apr; 41(4):720-730. PubMed ID: 33351265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
    Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
    J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological Characterization of HIV and SARS-CoV-2 Coinfected Young Individuals.
    Vanetti C; Trabattoni D; Stracuzzi M; Amendola A; Fappani C; Rubinacci V; Fenizia C; Gianolio L; Biasin M; Dighera A; Saulle I; Tanzi E; Zuccotti G; Clerici M; Giacomet V
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.